Rhenman & Partners Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-607,070	Closed	-$14.8M	–	98
2019 Q1	$14.8M	Sell	607,070 -90,300	-13%	-$2.2M	1.73%	22
2018 Q4	$9.94M	Sell	697,370 -71,000	-9%	-$1.01M	1.14%	42
2018 Q3	$11.7M	Buy	768,370 +45,000	+6%	+$684K	1.17%	41
2018 Q2	$12.1M	Buy	723,370 +21,900	+3%	+$367K	1.24%	39
2018 Q1	$11.4M	Buy	701,470 +198,411	+39%	+$3.24M	1.41%	32
2017 Q4	$6.44M	Sell	503,059 -146,941	-23%	-$1.88M	0.87%	48
2017 Q3	$8M	Buy	650,000 +225,000	+53%	+$2.77M	1.02%	38
2017 Q2	$3.56M	Buy	425,000 +75,000	+21%	+$628K	0.51%	68
2017 Q1	$3.13M	Sell	350,000 -200,000	-36%	-$1.79M	0.5%	67
2016 Q4	$4.84M	Hold	550,000	–	–	0.93%	42
2016 Q3	$3.71M	Buy	550,000 +180,000	+49%	+$1.22M	0.59%	59
2016 Q2	$1.32M	Hold	370,000	–	–	0.23%	84
2016 Q1	$1.09M	Hold	370,000	–	–	0.22%	86
2015 Q4	$1.56M	Hold	370,000	–	–	0.24%	89
2015 Q3	$1.69M	Hold	370,000	–	–	0.27%	83
2015 Q2	$2.67M	Sell	370,000 -30,000	-8%	-$216K	0.32%	86
2015 Q1	$2.95M	Sell	400,000 -145,000	-27%	-$1.07M	0.5%	71
2014 Q4	$2.58M	Buy	545,000 +165,801	+44%	+$784K	0.75%	56
2014 Q3	$1.35M	Buy	379,199 +50,000	+15%	+$179K	0.4%	87
2014 Q2	$1.5M	Hold	329,199	–	–	0.45%	74
2014 Q1	$1.55M	Sell	329,199 -30,801	-9%	-$145K	0.46%	74
2013 Q4	$1.8M	Buy	+360,000	New	+$1.8M	0.71%	59